Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2023-08-29

FDA Approved: RYALTRIS — Supplemental Application (HIKMA SPECIALTY USA INC.)

View source ↗

Summary

FDA approved a supplemental application for RYALTRIS (olopatadine hydrochloride and mometasone furoate) submitted by Hikma Specialty USA Inc., for labeling chan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RYALTRIS (OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE)

Snippet

SUPPL AP for RYALTRIS (OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE)